Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome (ELPIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02398604
Recruitment Status : Terminated (Study was closed due to Sponsor switched to Longeveron. New Identifier is NTC03525418)
First Posted : March 25, 2015
Last Update Posted : June 25, 2019
Sponsor:
Collaborator:
University of Maryland, College Park
Information provided by (Responsible Party):
Joshua M Hare, University of Miami

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2019
Actual Study Completion Date : March 2019